September 24, 2019, Suzhou has welcomed the coolness of early autumn, and the Dynamics 365 ERP project between IWS and Amerigen Pharmaceuticals has been officially launched.

Amerigen Pharmaceuticals Suzhou is a group of companies with multiple members in the United States and China, focusing on all phases of generic drugs. The group is controlled by Amerigen Pharmaceuticals. Registration and commercial activities for the US market are handled by Amerigen USA, located in Lynnhurst, New Jersey; the Group's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Ltd, is located in Suzhou, Jiangsu Province, China. During 2011-2012, and subsequently in 2015, Amerigen Suzhou made strategic capital investments and upgrades to ensure that products with more complex pharmaceutical processes are manufactured with the highest quality requirements.

Amerigen has accumulated many insurmountable problems during the year of using the D365 system. The establishment of a special project and the selection of IWS as the implementation partner to work together to solve these problems is a sign of trust in our ability and a confirmation of IWS's reputation in the industry.

After meeting with Amerigen's CFO, IT manager and finance department colleagues to sort out the system problems and related processes, we made a preliminary diagnosis and analysis of these problems. The problems were prioritized according to their depth and urgency, and analyzed one by one. Some of the problems were caused by the imperfect setup of the basic data in the customer system, while others were caused by the irregularities of the business process. According to the different qualities of these problems, preliminary solutions and project implementation plans were proposed.

We believe that with IWS professional implementation service team and adhering to the service tenet of "excellent, high quality and zero defect", we will be able to work together with Amerigen to complete the ERP project with high quality and efficiency.